Document:

Form of Stock Appreciation Rights Award Agreement

 Exhibit 10.2 

HEALTH INSURANCE INNOVATIONS, INC. 

LONG TERM INCENTIVE PLAN 

Stock Appreciation Rights Award Agreement 

(Stock-Settled) 
 You have
been granted Stock Appreciation Rights (this “Award”) on the following terms and subject to the provisions of Attachment A and the Long Term Incentive Plan (the “Plan”) of Health Insurance Innovations, Inc. (the
“Company”). Unless defined in this Award Agreement (including Attachment A, this “Agreement”), capitalized terms will have the meanings assigned to them in the Plan. In the event of a conflict among the provisions
of the Plan, this Agreement and any descriptive materials provided to you, the provisions of the Plan will prevail. 
  

			
	Participant		
                          
                               

		
	Number of Stock Appreciation Rights		40,000 (each a “SAR”)
		
	Exercise Price per SAR		$4.95
		
	Grant Date		July 1, 2015
		
	Expiration Date		July 1, 2022, subject to earlier termination under Section 2(d) of Attachment A.

 Vesting Schedule 

(subject to Section 2(c) and Section 2(d) of Attachment A) 
  

			
	Vesting		 Subject to Section 2(c) and Section 2(d) of Attachment A, the SARS shall vest and become exercisable in four tranches, on the following dates
in the following amounts:
  
 July 1, 2016: 10,000

July 1, 2017: 10,000
 July 1, 2018: 20,000

 Attachment A 

Stock Appreciation Rights Award Agreement 

(Stock-Settled) 
 Terms
and Conditions 
 Grant to:
                     

Section 1. Grant of Stock Appreciation Rights. Subject to the terms and conditions of the Plan and this Agreement, the Company
hereby grants this Award to the Participant on the Grant Date on the terms set forth on the cover page of this Agreement, as more fully described in this Attachment A. This Award is granted under the Plan, which is incorporated herein by this
reference and made a part of this Agreement. 
 Section 2. Terms of SAR. 

(a) Generally. Subject to the terms and conditions of this Agreement and the Plan, each SAR constitutes an unfunded and unsecured
promise of the Company to deliver to Participant, at the time such SAR is validly exercised, an amount, payable in the form of Shares, equal to the excess of (i) the Fair Market Value of one Share on the date of exercise, over (ii) the
Exercise Price per SAR set forth on the cover page of this Agreement (the “Spread”). 
 (b) Exercisability.
Subject to the terms and conditions of this Agreement and the Plan, a SAR may be exercised only after if it has vested and become exercisable under Section 2(c), and only before it has terminated under Section 2(d). 

(c) Vesting. 

(i) The SARs shall vest and become exercisable in accordance with the Vesting Schedule set forth on the cover page of this
Agreement; provided that the SARs shall vest on any date in such Vesting Schedule only if no Termination of Service occurs with respect to the Participant on or prior to such vesting date. If a Termination of Service occurs, all unvested SARs
shall terminate in accordance with Section 2(d)(ii). 
 (ii) If the Participant holds unvested SARs at the time a
Change in Control occurs, the SARs shall become 100% vested and exercisable on the date of the Change in Control immediately prior to the consummation thereof. 

(d) Termination. The SARs shall terminate at the time of termination set forth below: 

(i) All of the SARs shall terminate at 5:00 p.m., Eastern time, on the Expiration Date set forth on the cover page of this
Agreement, unless earlier terminated under subsections (ii) – (v) below. 
 (ii) In the event of the
Participant’s Termination of Service at any time and for any reason, the SARs, to the extent that they are not vested and exercisable at the time of the Termination of Service, shall terminate simultaneously with the Termination of Service.

  
 A-1 

 (iii) In the event of the Participant’s Termination of Service at any time
due to Termination for Cause, all of the SARs shall terminate simultaneously with the Termination of Service, including to the extent that the SARs are otherwise vested and exercisable at the time of the Termination of Service. 

(iv) In the event of the Participant’s Termination of Service at any time due to Termination Upon Death or Termination For
Disability, the SARs, to the extent that they are otherwise vested and exercisable at the time of the Termination of Service, shall terminate at 5:00 p.m., Eastern time, on the date that is one year after the date of the Termination of Service. 

(v) In the event of the Participant’s Termination of Service for any reason not specified in subsections (iii) or
(iv) above, the SARs, to the extent that they are otherwise vested and exercisable at the time of the Termination of Service, shall terminate at 5:00 p.m., Eastern time, on the date that is ninety (90) days after the date of the
Termination of Service. 
 For purposes of this Agreement, Termination for Cause, Termination Upon Death and Termination For Disability shall have the
respective meanings set forth in the Employment Agreement, dated as of July 14, 2014, by and between the Participant and the Company, as the same has been and may be amended by the parties from time to time. 

Upon termination, all affected SARs shall automatically be forfeited to the Company without consideration, and, if otherwise vested and exercisable, shall
cease to be exercisable. For clarity, in no event shall any SAR be exercisable after the Expiration Date set forth on the cover page of this Agreement. 

(e) Transferability. The SARs, and the Participant’s rights under this Agreement, shall not be assigned, sold, transferred or
otherwise be subject to alienation by the Participant, other than by will or the law of descent and distribution, and any purported assignment, sale, transfer or other alienation not permitted hereunder shall be void. During the Participant’s
lifetime, the SARs shall be exercisable only by the Participant. 
 Section 3. Exercise. 

(a) When to Exercise. Except as otherwise provided in the Plan or this Agreement, the Participant (or in the case of exercise after the
Participant’s death or incapacity, the Participant’s guardian, legal representative, heir or legatee, as the case may be) may exercise his or her SARs that are then exercisable under Section 2, in whole or in part, by following
the procedures set forth in this Section 3. If partially exercised, the Participant (or in the case of exercise after the Participant’s death or incapacity, the Participant’s guardian, legal representative, heir or legatee, as
the case may be) may thereafter exercise the remaining unexercised portion of the SARs, to the extent that they are then exercisable under Section 2, by following the procedures set forth in this Section 3. 

  
 A-2 

 (b) Election to Exercise. To exercise the SARs, the Participant (or in the case of
exercise after the Participant’s death or incapacity, the Participant’s guardian, legal representative, heir or legatee, as the case may be) must deliver to the Secretary of the Company (or his or her designee) a written notice (or notice
through another previously approved method, which could include a web-based or e-mail system) which sets forth the number of SARs being exercised, together with any additional documents as the Company may require. Each such notice must satisfy
whatever then-current procedures apply to the SARs and must contain such representations, warranties and covenants as the Company requires. If someone other than the Participant exercises the SARs, then such person must submit documentation
reasonably acceptable to the Company verifying that such person has the legal right to exercise the SARs. 
 (c) Date of Exercise.
The SARs shall be deemed to be exercised on the business day that the Company receives a fully executed and completed exercise notice. If an exercise notice is received on a day that is not a business day, or is received after 5:00 p.m., Eastern
time, on a business day, then the SARs shall be deemed to be exercised on the first business day immediately following the day such notice is received by the Company. 

(d) Settlement. Upon a valid exercise of SARs, the Participant shall be entitled to receive that number of Shares determined by
dividing (i) (1) the total number of SARs then being exercised, multiplied by (2) the Spread on the date of exercise, by (ii) the Fair Market Value of one Share on the date of exercise. 

(e) Fractional Shares. No fractional Shares shall be issued upon exercise of SARs, and if the number of Shares otherwise issuable under
Section 3(d) upon an exercise of SARs includes a fraction of a Share, then upon such exercise the Participant shall be entitled to receive (i) the number of Shares determined under Section 3(d), rounded down to the
nearest whole Share, plus (ii) an amount of cash equal to the Fair Market Value of one Share on the date of exercise, multiplied by such fraction of a Share. 

(f) Withholding Requirements. The delivery of Shares upon settlement of SARs is conditioned on the Participant making arrangements
satisfactory to the Company to enable the Company to satisfy all tax (or other governmental obligation) withholding requirements. In the event that there is any such withholding requirement upon an exercise of SARs, the Committee may, in its sole
discretion and pursuant to such procedures as the Committee may require, permit the Participant to satisfy any such withholding requirement by having the Company withhold from the number of Shares otherwise issuable to the Participant upon such
exercise a number of Shares having an aggregate Fair Market Value equal to the minimum amount required to be withheld. If the Committee permits the Participant to satisfy any such withholding requirement pursuant to the preceding sentence, the
Company shall remit to the Internal Revenue Service and appropriate state and local revenue agencies, for the credit of the Participant, an amount of cash withholding equal to the Fair Market Value of the Shares withheld by the Company as provided
above. 
 (g) Compliance with Law and Regulations. The SARs, their exercise and the obligation of the Company to issue Shares in
settlement thereof are subject to all applicable federal and state laws, rules and regulations, including securities laws, to approvals by any government or 

  
 A-3 

 
regulatory agency as may be required, and to the rules, regulations and other requirements of the stock market or exchange upon which the Shares are then quoted, traded or listed. The Participant
may not exercise a SAR if such exercise would violate any securities laws or other applicable law, rule, regulation or requirement. 

Section 4. No Rights of Stockholder. A holder of a SAR, as such, shall not be entitled to vote or receive dividends or be deemed
the holder of the Shares underlying the SAR for any purpose, nor shall anything contained in this Agreement be construed to confer upon the holder of a SAR, as such, any of the rights or obligations of a stockholder of the Company, unless and until
Shares are actually issued to and held of record by such holder upon settlement of the SARs following valid exercise thereof. 

Section 5. Change in Control. Without limiting the Committee’s power under the Plan, upon the occurrence of a Change in
Control, the Committee is authorized (but not obligated) to make adjustments to the terms and conditions of the SARs without the need for the consent of the Participant, including, without limitation, the following (or any combination thereof): 

(a) The Committee may provide for the continuation or assumption of the SARs and this Agreement by the acquiring or successor entity (or
parent thereof), including the Company if it is the surviving entity, or for the substitution of the SARs and this Agreement with a substitute award with terms comparable to the SARs and this Agreement (in each case with appropriate adjustments as
to the Exercise Price and the number and type of Shares (or other securities) underlying the Award or substitute award). The determination of such appropriate adjustments and comparability shall be made by the Committee. 

(b) The Committee may provide for the cancellation of all or any portion of the SARs for their Intrinsic Value (payable in the form of cash,
stock, securities, other property or any combination thereof) based upon the price per Share received or to be received by other stockholders of the Company in the Change in Control transaction. If at the time of a Change in Control such Intrinsic
Value is equal to or less than zero (i.e., the Exercise Price of the SARs equals or exceeds the price per Share received or to be received by other stockholders of the Company in the Change in Control transaction), then the Committee may provide for
the cancellation of the SARs without the payment of any consideration therefor. 
 Section 6. Miscellaneous Provisions. 

(a) Notices. All notices, requests and other communications under this Agreement (other than a notice of exercise, which shall be
provided in accordance with Section 3) shall be in writing and shall be delivered in person (by courier or otherwise), mailed by certified or registered mail, return receipt requested, or sent by facsimile transmission, as follows: 

  
 A-4 

 if to the Company, to: 

Health Insurance Innovations, Inc. 

15438 N. Florida Avenue, Suite 201 

Tampa, Florida, 33613 
 Attention:
President 
 Telecopy: (877) 376-5832 

with a copy to (which shall not constitute notice hereunder): 

Health Insurance Innovations, Inc. 

15438 N. Florida Avenue, Suite 201 

Tampa, Florida, 33613 
 Attention:
Chief Financial Officer 
 Telecopy: (877) 376-5832 

if to the Participant, to the address that the Participant most recently provided to the Company, 

or to such other address or facsimile number as such party may hereafter specify for the purpose by notice to the other parties hereto. All such notices,
requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed
received on the next succeeding business day in the place of receipt. 
 (b) Entire Agreement. This Agreement, the Plan and any other
agreements referred to herein and therein and any attachments referred to herein or therein, constitute the entire agreement and understanding between the parties in respect of the subject matter hereof and supersede all prior and contemporaneous
arrangements, agreements and understandings, both oral and written, whether in term sheets, presentations or otherwise, between the parties with respect to the subject matter hereof. 

(c) Amendment; Waiver. No amendment or modification of any provision of this Agreement shall be effective unless signed in writing by
or on behalf of the Company and the Participant, except that the Committee may amend or modify this Agreement without the Participant’s consent in accordance with the provisions of the Plan or as otherwise set forth in this Agreement. No waiver
of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition whether of like or different nature. Any amendment or modification of or to any provision of this Agreement, or any waiver of
any provision of this Agreement, shall be effective only in the specific instance and for the specific purpose for which made or given. 

(d) Successors and Assigns; No Third Party Beneficiaries. This Agreement shall inure to the benefit of and be binding upon the Company
and the Participant and their respective heirs, successors, legal representatives and permitted assigns. Nothing in this Agreement, expressed or implied, is intended to confer on anyone other than the Company and the Participant, and their
respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement. 

  
 A-5 

 (e) Counterparts. This Agreement may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 (f) Plan.
The Participant acknowledges and understands that material definitions and provisions concerning this Award and the Participant’s rights and obligations with respect thereto are set forth in the Plan. The Participant has read carefully, and
understands, the provisions of the Plan. 
 (g) Governing Law. The Agreement shall be governed by the laws of the State of Florida,
without application of the conflicts of law principles thereof. 
 (h) No Right to Continued Service. The granting of the Award
evidenced hereby and this Agreement shall impose no obligation on the Company or any Affiliate to continue the service of the Participant and shall not lessen or affect the right that the Company or any Affiliate may have to terminate the service of
such Participant. 
 (i) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN
ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 [SIGNATURE PAGE FOLLOWS] 

  
 A-6 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first written
above. 
  

			
	HEALTH INSURANCE INNOVATIONS, INC.
		
	By:		 
	
	PARTICIPANT
	
	  

  
  

 
  

(Signature Page to Stock Appreciation Rights Award Agreement)SETTLEMENT
AGREEMENT AND RELEASE

 

This
Settlement Agreement and Release (the “Agreement”) is made this 1st day of July, 2015 (the “Effective Date”),
by and among Earl Kopriva (“Kopriva”), and Geoffrey J. Thompson, Nancy Thompson, GWS Financial Services, Inc., Synergistic
Holdings, LLC, Accelera Innovations, Inc. (collectively, “Accelera Parties”), and Robert C. Acri (“Acri”),
with full knowledge of the facts with respect to the dispute described below. Kopriva, the Accelera Parties and Acri are hereafter
sometimes referred to as the “Parties.”

 

RECITALS

 

A.
On or about February 10, 2014, the Accelera Parties and Kopriva entered into a Forbearance Agreement, which was an attempt to
resolve a dispute between them over what Kopriva claimed to be an unpaid debt.

 

B.
Kopriva claimed that the Accelera Parties breached the Forbearance Agreement.

 

C.
On August 12, 2014 Kopriva filed a lawsuit against the Accelera Parties in the United States District Court for the Western District
of Oklahoma, in Case No. CIV-14-854-C, Kopriva v. Thompson, et al. (the “Lawsuit”).

 

D.
On August 26, 2014, Kopriva filed an amended complaint adding Acri as a party in the same Lawsuit.

 

E.
Kopriva, the Accelera Parties and Acri desire, by this Agreement, to resolve all disputes with regard to the matters set forth
herein. Kopriva, the Accelera Parties and Acri specifically agree that this Agreement is being made in order to settle the Lawsuit
and that this Agreement is in no way to be construed as an admission of liability on the part of any of the Parties.

 

OBLIGATIONS
OF THE PARTIES

 

In
consideration of the mutual covenants as herein set forth, the Parties agree as follows:

 

1.
Kopriva Dismissal of Fraud Claim. Not later than July 7, 2015, Kopriva shall file a Dismissal without Prejudice of the
fraud claim asserted against the Accelera Parties and Acri in the Lawsuit. By this dismissal, Kopriva reserves the right to reassert
the fraud claim at a later date, except as provided below in paragraph 2. The Accelera Parties and Acri agree to not oppose this
Dismissal without Prejudice.

 

2.
Accelera Parties and Acri Confession of Judgment. Not later than July 7, 2015, the Accelera Parties and Acri shall execute
a Confession of Judgment (the “Judgment” attached as Exhibit 1) of all remaining causes of action asserted against
them in the Lawsuit and the damages shall be stipulated as being $110,000 against the Accelera Parties and Acri, jointly and severally,
along with any of Kopriva’s attorneys’ fees and costs incurred in executing and collecting on the Judgment.

 

    	 

    	 

    

 

3.
Kopriva’s Forbearance from Execution on the Judgment. Kopriva shall forbear from executing on the Judgment so long
as the Accelera Parties and Acri make the payments as provided below in paragraph 4. Upon Kopriva’s receipt of the final
payment on or before May 1, 2016, along with the timely payment of all prior payments, he shall file a Satisfaction of Judgment
with the court in which the Lawsuit was filed. If the Accelera Parties and Acri fail to make any of the payments provided below,
then Kopriva may immediately begin executing on the Judgment.

 

4.
Accelera Parties and Acri Payments. The Accelera Parties and Acri will pay Kopriva $84,000 in good and immediately available
funds (no later than the close of business of the below designated dates) as follows:

 

	(1)
    July 1, 2015	$14,000.	(7)	January
    1, 2016	$7,000.
	(2) August 1, 2015	$7,000.	(8)	February 1, 2016	$7,000.
	(3) September 1, 2015	$7,000.	(9)	March 1, 2016	$7,000.
	(4) October 1, 2015	$7,000.	(10)	April 1, 2016	$7,000.
	(5) November 1, 2015	$7,000.	(11)	May 1, 2016	$7,000.
	(6) December 1, 2015	$7,000.	 	 	 

 

a.
The payments shall be made by wire or cashier’s check to the trust account of National Litigation Law Group, PLLC, at:

 

If
by Wire, then:

 

	 	Acct.:	National Litigation
    Law Group, PLLC Trust Acct
	 	Bank:	Oklahoma State
    Bank
	 	ABA No.:	303087995
	 	Account No.:	6701014153
	 	Contact:	Luana Pender (405.429.7609)
	 	 	 
	 	If by Cashier’s	 
	 	Check,
    then:	National Litigation
    Law Group, PLLC Trust Account
	 	 	2401 Northwest
    Twenty-Third Street, Suite 42
	 	 	Oklahoma City,
    OK 73107
	 	 	Attn.: Luana Pender
    (405.429.7609)

 

b.
Time is of an essence. There shall be no grace period and no cure opportunity to make up for a missed or late payment.

 

5.
Accelera Shares and Stock Certificates.

 

a.
On or before July 1, 2015, the Accelera Parties will provide Kopriva stock certificates representing 350,000 shares in Accelera
Innovations, LLC. Accelera Innovations, Inc. agrees to use its reasonable best efforts to cause its transfer agent (i) to remove,
on or before July 1, 2015, any restrictive legends from stock certificates held by Kopriva representing 350,000 shares of Accelera
Innovations, Inc. common stock, and (ii) to issue, on or before July 1, 2015, stock certificates representing such shares free
of any restrictive legends, such that the shares will not be subject to any Lock-Up or Leak-Out restriction and Kopriva will be
free to immediately sell or otherwise dispose of such shares. Kopriva agrees to provide Accelera Innovations, Inc. any and all
information and documentation reasonably requested by Accelera Innovations, Inc. in connection with the removal of restrictive
legends from the stock certificates.

 

    	2

    	 

    

 

b.
Additionally, Accelera Innovations, Inc. agrees to issue to Kopriva, on or before July 1, 2015, 25,000 shares of Accelera Innovations,
Inc. common stock. Accelera Innovations, Inc. and Kopriva agree that the stock certificates representing such shares will bear
a legend in substantially the following form:

 

THE
SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE
WITH THE TERMS OF A LOCK-UP AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST
TO THE SHARES). THE SECRETARY OF THE COMPANY WILL, UPON WRITTEN REQUEST, FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF
WITHOUT CHARGE,

 

Such
shares shall be subject to a Lock-Up Period of six (6) months from the date that the Common Stock (as that term is defined in
the Lock-Up Agreement) commences trading on the NASDAQ, during which time Kopriva shall not sell, trade, transfer or otherwise
dispose of these 25,000 shares.

 

c.
Kopriva will have all of the rights and benefits of any other similar classed Accelera shareholder.

 

6.
General Release of Kopriva. The Accelera Parties, collectively and individually, and Acri, along with their respective
agents, heirs, successors and assigns, upon signing this Agreement and in consideration hereof, hereby release and discharge Kopriva,
and any related or affiliated companies, successors, assigns, attorneys and insurance carriers, and each of them, of and from
any and all administrative, civil, judicial and other actions, causes of actions, claims, counterclaims, third-party claims, suits,
demands, damages, costs, loss of services, expenses, attorneys’ fees or compensation arising out of anything which has occurred
at any time up to and including the Effective Date of this Agreement, whether known or unknown, and specifically including all
claims, counterclaims or other actions which might or could be brought from or arising out of anything that is the subject of
the Lawsuit, or the facts outlined in the Recitals section. The obligations created by this Agreement are excluded until satisfied.

 

7.
General Release of the Accelera Parties and Acri. Kopriva, along with his agents, heirs, successors and assigns, upon the
Accelera Parties and Acri’s satisfaction of each and all of their obligations under this Agreement and in consideration
hereof, hereby releases and discharges the Accelera Parties and Acri, and any parent, subsidiary, related or affiliated companies,
members, managers, principals, officers, directors, agents, servants, employees, successors, assigns, attorneys, insurance carriers,
heirs, successors and assigns, and each of them, of and from any and all administrative, civil, judicial and other actions, causes
of actions, claims, counterclaims, third-party claims, suits, demands, damages, costs, loss of services, expenses, attorneys’
fees or compensation arising out of anything which has occurred at any time up to and including the Effective Date of this Agreement,
whether known or unknown, and specifically including all claims, counterclaims or other actions which might or could be brought
from or arising out of anything that is the subject of the Lawsuit, or the facts outlined in the Recitals section. The obligations
created by this Agreement are excluded until satisfied.

 

8.
Assignment. Each of the Parties represents that it has not conveyed, sold, assigned, or otherwise transferred to any third
party any portion of its claims being released, discharged, or dismissed by virtue of this Agreement. Each of the Parties represents
that it is the lawful owner of all claims asserted by it in the subject matter and that it has not assigned, pledged, or in any
manner sold or transferred any right, title, or interest in such claims. Neither this Agreement, nor any interest herein, shall
be assigned by any Party without the prior written consent of the other Parties.

 

9.
Warranty of Capacity to Execute Agreement. Each of the Parties warrants and represents on behalf of itself that it has
full power and authority to enter into this Agreement and to bind the Parties, that any and all necessary consents and approvals
have been obtained, and that no other consent, approval or action is required.

 

    	3

    	 

    

 

10.
Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective
legal representatives, successors, assigns and heirs.

 

11.
Advice of Counsel. The Parties each have had access to and the benefit of legal counsel and advice in negotiating, reviewing
and executing this Agreement: Robert J. Haupt of National Litigation Law Group, PLLC on behalf of Kopriva and Lisa Bachman of
Foley Mansfield, LP on behalf of the Accelera Parties and Acri.

 

12.
Attorney Fees for Underlying Dispute. The Parties shall bear their own attorney’s fees and costs with regard to the
Lawsuit and the settlement thereof.

 

13.
Enforcement of Agreement. In the event that any Party must bring an action to enforce the terms of this Agreement, or any
part of it, the prevailing party shall be entitled to its reasonable costs and attorney fees.

 

14.
Choice of Law and Venue. The Parties expressly agree that this Agreement shall be governed by the laws of the State of
Oklahoma and any action to enforce this Agreement shall be brought in Oklahoma County, Oklahoma.

 

15.
Interpretation. The terms and language of this Agreement are the result of negotiations between the Parties and their respective
counsel and there shall be no presumption that any ambiguities in this Agreement should be resolved against any party to this
Agreement. Any controversy concerning the construction or interpretation of this Agreement shall be decided neutrally, in light
of conciliatory purposes, and without regard to authorship.

 

16.
Severability. If any provision, or portion of a provision, is found to be unenforceable or invalid, such unenforceability
or invalidity shall not render this Agreement, or any other portion of it, unenforceable or invalid, and such provision or portion
of such provision shall be changed or interpreted so as to best accomplish the objectives of such unenforceable or invalid provision,
within the limits of the applicable law.

 

17.
Counterparts. This Agreement may be executed in one or more counterparts, each of which will constitute one and the same
instrument. Fax copies and digital copies (in portable document, tagged image file or similar format) of manually signed counterparts
of this Agreement shall be deemed manually signed for all purposes. Each party is authorized to rely on facsimile or other imaged
(e.g. “pdf” or “tiff”) signatures of the parties as having the same force and effect as the receipt of
an original signature of each party.

 

18.
Entire Agreement. This Agreement represents the whole understanding and agreement of the Parties hereto, and this Agreement
supersedes any prior negotiation or agreement between the Parties with respect to such matters. This Agreement may not be amended,
modified or supplemented except by a written instrument executed by the Parties hereto. No party has made any representations
with respect to the settlement of the claims of the Parties other than those contained herein.

 

[SIGNATURE
PAGES FOLLOW]

 

    	4

    	 

    

 

	 	GEOFFREY
    J. THOMPSON
	 	 
	 	/s/
    Geoffrey J. Thompson

 

 

	STATE OF ILLINOIS	)
	 	) SS.
	COUNTY OF WILL	)

 

SUBSCRIBED
AND SWORN to before me on July 1, 2015, by Geoffrey J. Thompson.

 

	 	 	 	/s/
    Nicole C. Leheney
	(SEAL)	 	Notary Public
	 	 	 
	My Commission
    Expires:	 05-29-2017	 
	 	 	 
	Commission
    No.:	 	 

 

    	5

    	 

    

 

	 	NANCY
    THOMPSON
	 	 
	 	/s/ Nancy Thompson

  

	STATE OF ILLINOIS	)
	 	) SS.
	COUNTY OF WILL	)

 

SUBSCRIBED
AND SWORN to before me July 1, 2015, by Nancy Thompson.

 

	 	 	 	 	/s/
    Nicole C. Leheney
	(SEAL)	 		Notary Public
	 	 	 	 
	My
    Commission Expires:	 05-29-2017	 	 
	 	 	 	 
	 	 	 	 
	Commission
    No.:	 	 	 

 

    	6

    	 

    

 

	 	GWS FINANCIAL SERVICES, INC.
	 	 	 
	 	By:	/s/ Geoffrey
    J. Thompson
	 	 	Geoffrey
    J. Thompson
	 	 	President

 

	STATE OF ILLINOIS	)
	 	) SS.
	COUNTY OF WILL	)

 

SUBSCRIBED
AND SWORN to before me July 1, 2015, by Geoffrey J. Thompson, President of GWS Financial Services, Inc.

 

	 	 	 	 	/s/
    Nicole C. Leheney
	(SEAL)	 		Notary Public
	 	 	 	 
	My Commission
    Expires:	05-29-2017	 	 
	 	 	 	 
	 	 	 	 
	Commission
    No.:	 	 	 

 

    	7

    	 

    

 

	 	SYNERGISTIC HOLDINGS, LLC.
	 	 	 
	 	By:	/s/ Geoffrey
    J. Thompson
	 	Name:	Geoffrey
    J. Thompson
	 	 	Manager

 

	STATE OF ILLINOIS	)
	 	) SS.
	COUNTY OF WILL	)

 

SUBSCRIBED
AND SWORN to before me July 1, 2015, by Geoffrey J. Thompson, Manager of Synergistic Holdings, LLC.

 

	 	 	 	 	/s/
    Nicole C. Leheney
	(SEAL)	 		Notary Public
	 	 	 	 
	My Commission
    Expires:	05-29-2017	 	 
	 	 	 	 
	Commission
    No.:	 	 	 

 

    	8

    	 

    

 

	 	ACCELERA INNOVATIONS, INC.
	 	 	 
	 	By:	/s/
    John F. Wallin
	 	 	John
    F. Wallin
	 	 	President

 

	STATE OF ILLINOIS	)
	 	) SS.
	COUNTY OF WILL	)

 

SUBSCRIBED
AND SWORN to before me June 30, 2015, by John F. Wallin, President of Accelera Innovations, Inc.

 

	 	 	 	 	/s/
    Nicole C. Leheney
	(SEAL)	 		Notary Public
	 	 	 	 
			 	 
	My
    Commission Expires:	March
    26, 2018 	 	 
	 	 	 	 
	Commission
    No.:	 	 	 

 

    	9

    	 

    

 

	 	ROBERT
    C. ACRI
	 	 
	 	/s/ Robert
    C. Acri

 

	STATE OF IL	)
	 	) SS.
	COUNTY OF COCK	)

 

SUBSCRIBED
AND SWORN to before me July 1, 2015, by Robert C. Acri.

 

	 	 	 	 	/s/
    Debbie Williams
	(SEAL)	 	 	Notary Public
	 	 	 	 
	My
    Commission Expires:	 05/07/2019	 	 
	 	 	 	 
	Commission
    No.:	522375	 	 

  

    	10

    	 

    

 

	 	EARL
    KOPRIVA
	 	 
	 	/s/ Earl Kopriva

 

	STATE OF Minnesota	)
	 	) SS.
	COUNTY OF Hennepin	)

 

SUBSCRIBED
AND SWORN to before me July 1, 2015, by Earl Kopriva.

 

	 	 	 	 	/s/
    Sheryl L. Hoye
	(SEAL)	 	 	Notary Public
	 	 	 	 
	My Commission
    Expires:	1-31-19	 	 
	 	 	 	 
	Commission
    No.:	 	 	 
		 	 	 

 

    	11

    	 

    

 

 

    	 

    	 

    

 

 

 

    	2

    	 

    

  

 

    	3

    	 

    

 

 

 

    	4

    	 

    

 

 

    	5

    	 

    

 

EXHIBIT A

 

    	6

    	 

    

 

 

 

    	7

    	 

    

 

 

 

    	8

    	 

    

 

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]